Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
about
Epidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysLapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes.Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancerAtypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature.Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathwayReceptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.Novel targeted therapies and immunotherapy for advanced thyroid cancers.NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3.
P2860
Q33737298-F6B332B2-657D-4E60-BBFA-6D50F40BDE80Q36232153-FCA5DB59-5A24-4891-9485-894E9EF68EEAQ36306149-BB984763-7270-4B8D-9EEF-B0D994CBB093Q38738465-F979C84C-ECE6-480D-B0AC-A750713EF7B3Q41518094-DAA19B05-EEB5-4B84-930E-B1D2CAFA3EF9Q41623567-BB7F7ED4-713B-4FCD-B211-805884342D9EQ49887925-0FBA0ECB-33B9-4BCA-8195-99B542AA9893Q49887965-3D38A666-0663-43AF-A110-AE0E09FE1B56Q54978331-A75D74A6-4A76-4071-9066-959753F74423Q55439726-914B0FA8-83BC-488A-80E8-8BDE5F112CAB
P2860
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@ast
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@en
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@nl
type
label
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@ast
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@en
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@nl
prefLabel
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@ast
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@en
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@nl
P2860
P1476
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.
@en
P2093
P2860
P304
P577
2014-11-19T00:00:00Z